Notably, in the literature, it was found that SNORD44 is downregulated in breast cancer and associated with a poor prognosis, whereas SNORD118 was upregulated in breast cancer and its depletion inhibited tumorigenicity of breast cancer cells in vivo and in vitro [66]. The gene discussed is SNORD118; the disease is breast cancer.